Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods

Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods Journal Article uri icon

Overview

Link to Article

10.1001/jamanetworkopen.2023.2598

authors

Link-Gelles, R.

Levy, M. E.

Natarajan, K.

Reese, S. E.

Naleway, A. L.

Grannis, S. J.

Klein, N. P.

DeSilva, Malini B., MD, MPH HealthPartners Author

Ong, T. C.

Gaglani, M.

Hartmann, E.

Dickerson, M.

Stenehjem, E.

Kharbanda, A. B.

Han, J.

Spark, T. L.

Irving, S. A.

Dixon, B. E.

Zerbo, O.

McEvoy, Charlene E., MD, MPH HealthPartners Author

Rao, S.

Raiyani, C.

Sloan-Aagard, C.

Patel, P. D.

Dascomb, K.

Uhlemann, A. C.

Dunne, M. M.

Fadel, W. F.

Lewis, N.

Barron, M. A.

Murthy, K.

Nanez, J.

Griggs, E. P.

Grisel, N.

Annavajhala, M. K.

Akinseye, A.

Valvi, N. R.

Goddard, K. A. B.

Mamawala, M.

Arndorfer, J.

Yang, D. H.

Embí, P. J.

Fireman, B. H.

Ball, S. W.

Tenforde, M. W.

publication date

2023

published in

JAMA network open Journal

Research

keywords

COVID-19

COVID-19 Vaccines

Case-Control Studies

Coronavirus Infections

Hospitalization

Prevention

Vaccination